1. Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19

   • Elizabeth Leung
   • Ryan L. Crass
   • Nathaniel J. Rhodes

   Review Article 11 December 2021 Pages: 155 - 165

   

2. Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions

   • Robert Hermann
   • Peter Krajcsi
   • Alain Munafo

   Review Article Open access 11 December 2021 Pages: 167 - 187

3. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature

   • Samuel Dubinsky
   • Kevin Watt
   • Andrea Edginton

   Systematic Review 30 November 2021 Pages: 189 - 229

   

4. Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study

   • Dirk Jan A. R. Moes
   • David J. van Westerloo
   • Judith van Paassen

   Original Research Article Open access 11 October 2021 Pages: 231 - 247

   

5. Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model

   • Lisa Ferguson-Sells
   • Nieves Velez de Mendizabal
   • David Small

   Original Research Article Open access 11 August 2021 Pages: 249 - 262

   

6. Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia

   • Ming Liang Chan
   • Yulan Qi
   • Joshua Henshaw

   Original Research Article Open access 25 August 2021 Pages: 263 - 280

   

7. Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption

   • Neil A. Miller
   • Rebecca H. Graves
   • Edith M. Hessel

   Original Research Article Open access 30 August 2021 Pages: 281 - 293

   

8. Age-Related Change in Hepatic Clearance Inferred from Multiple Population Pharmacokinetic Studies: Comparison with Renal Clearance and Their Associations with Organ Weight and Blood Flow

   • Kuretake Soejima
   • Hiromi Sato
   • Akihiro Hisaka

   Original Research Article 13 September 2021 Pages: 295 - 305

   

9. Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling

   • Jacqueline G. Gerhart
   • Fernando O. Carreño
   • the Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee

   Original Research Article Open access 07 October 2021 Pages: 307 - 320

   

10. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates

    • Wan-Yu Chu
    • Kim V. Annink
    • the ALBINO Study Group

    Original Research Article Open access 07 October 2021 Pages: 321 - 333

    

11. Comment on: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”

    • Pieter-Jan De Sutter
    • Jan De Waele
    • An Vermeulen

    Letter to the Editor 07 January 2022 Pages: 335 - 336

12. Authors’ Reply to De Sutter, De Waele, and Vermeulen: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”

    • Emily N. Drwiega
    • Keith A. Rodvold

    Letter to the Editor 04 January 2022 Pages: 337 - 338